A05995 Summary:

BILL NOA05995
 
SAME ASSAME AS S03297
 
SPONSORBarrett
 
COSPNSR
 
MLTSPNSR
 
Amd §§6527, 6909 & 6801, Ed L
 
Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis.
Go to top    

A05995 Actions:

BILL NOA05995
 
03/30/2023referred to higher education
01/03/2024referred to higher education
Go to top

A05995 Committee Votes:

Go to top

A05995 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A05995 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          5995
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                     March 30, 2023
                                       ___________
 
        Introduced  by M. of A. BARRETT -- read once and referred to the Commit-
          tee on Higher Education
 
        AN ACT to amend the education law, in relation  to  authorizing  pharma-
          cists to dispense HIV pre-exposure and post-exposure prophylaxis
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Subdivision 7-a of section 6527 of the  education  law,  as
     2  added by chapter 502 of the laws of 2016, is amended to read as follows:
     3    7-a.  A  licensed physician may prescribe and order a patient specific
     4  order or non-patient specific order to a licensed  pharmacist,  pursuant
     5  to  regulations promulgated by the commissioner in consultation with the
     6  commissioner of health, and consistent with the public health  law,  for
     7  dispensing  up  to a seven day starter pack of HIV post-exposure prophy-
     8  laxis  for  the  purpose  of  preventing  human  immunodeficiency  virus
     9  infection following a potential human immunodeficiency virus exposure. A
    10  licensed  physician  may  also prescribe and order a patient specific or
    11  non-patient specific order to a licensed pharmacist, pursuant  to  regu-
    12  lations promulgated by the commissioner in consultation with the commis-
    13  sioner  of health, and consistent with the public health law and section
    14  sixty-eight hundred one of this title, for HIV pre-exposure prophylaxis,
    15  provided, however, that the regulations  promulgated  pursuant  to  this
    16  subdivision  shall require that the HIV pre-exposure prophylaxis author-
    17  ized to be dispensed by a licensed pharmacist shall provide for at least
    18  a thirty-day, but no more than a sixty-day, supply of such prophylaxis.
    19    § 2. Subdivision 8 of section 6909 of the education law, as  added  by
    20  chapter 502 of the laws of 2016, is amended to read as follows:
    21    [8.]  11.  A  certified  nurse  practitioner may prescribe and order a
    22  patient specific order or non-patient specific order to a licensed phar-
    23  macist, pursuant to  regulations  promulgated  by  the  commissioner  in
    24  consultation  with  the  commissioner of health, and consistent with the
    25  public health law, for dispensing up to a seven day starter pack of  HIV
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01383-02-3

        A. 5995                             2
 
     1  post-exposure  prophylaxis for the purpose of preventing human immunode-
     2  ficiency virus infection following a  potential  human  immunodeficiency
     3  virus  exposure.  A  certified nurse practitioner may also prescribe and
     4  order  a  patient  specific  or non-patient specific order to a licensed
     5  pharmacist, pursuant to regulations promulgated by the  commissioner  in
     6  consultation  with  the  commissioner of health, and consistent with the
     7  public health law and section sixty-eight hundred one of this title, for
     8  HIV pre-exposure prophylaxis, provided, however,  that  the  regulations
     9  promulgated  pursuant  to  this  subdivision  shall require that the HIV
    10  pre-exposure prophylaxis authorized to be dispensed by a licensed  phar-
    11  macist  shall  provide  for  at  least  a thirty-day, but no more than a
    12  sixty-day, supply of such prophylaxis.
    13    § 3. Subdivision 5 of section 6801 of the education law, as  added  by
    14  chapter  502  of the laws of 2016, is amended and a new subdivision 9 is
    15  added to read as follows:
    16    5. A licensed pharmacist may execute a non-patient specific order, for
    17  dispensing up to a seven day starter pack of HIV  post-exposure  prophy-
    18  laxis  medications  for the purpose of preventing human immunodeficiency
    19  virus infection, by a physician licensed in this state or nurse  practi-
    20  tioner  certified  in  this  state,  pursuant  to  rules and regulations
    21  promulgated by the commissioner in consultation with the commissioner of
    22  health following a potential human immunodeficiency virus exposure.  The
    23  pharmacist  shall also inform the patient of the availability of pre-ex-
    24  posure prophylaxis for persons who are at substantial risk of  acquiring
    25  HIV.
    26    9. A licensed pharmacist may execute a non-patient specific order, for
    27  dispensing  HIV  pre-exposure  prophylaxis,  pursuant to rules and regu-
    28  lations promulgated by the commissioner in consultation with the commis-
    29  sioner of health provided,  however,  that  the  rules  and  regulations
    30  promulgated  pursuant  to  this  subdivision  shall require that the HIV
    31  pre-exposure prophylaxis authorized to be dispensed by a licensed  phar-
    32  macist  shall  provide  for  at  least  a thirty-day, but no more than a
    33  sixty-day, supply of such prophylaxis. And provided, further,  that  the
    34  following  conditions shall be met before a pharmacist may dispense pre-
    35  exposure prophylaxis:
    36    (a) The pharmacist has completed a training  program  created  by  the
    37  department  of health on the use of pre-exposure prophylaxis. The train-
    38  ing program shall educate pharmacists about  the  requirements  of  this
    39  subdivision,  the  risks  and  side  effects  of the medication, patient
    40  insurance and cost burdens, and any other  information  such  department
    41  deems necessary or important;
    42    (b)  The patient is HIV negative, as documented by a negative HIV test
    43  result  obtained  within  the  previous   seven   days   from   an   HIV
    44  antigen/antibody  test  or antibody-only test or from a rapid, point-of-
    45  care fingerstick blood test approved by the federal food and drug admin-
    46  istration. If the patient does not provide evidence of  a  negative  HIV
    47  test  in accordance with this paragraph, the pharmacist may recommend an
    48  HIV test. If the patient tests positive for HIV infection,  the  pharma-
    49  cist  shall  direct  the patient to a licensed physician and provide the
    50  patient with a list of health care service providers and clinics  within
    51  the county where the pharmacist is located or adjacent counties;
    52    (c)  The  patient  does  not report any signs or symptoms of acute HIV
    53  infection on a self-reported checklist of acute HIV infection signs  and
    54  symptoms;
    55    (d)  The  patient  does  not report taking any contraindicated medica-
    56  tions;

        A. 5995                             3
 
     1    (e) The pharmacist does not furnish more than a  sixty-day  supply  of
     2  pre-exposure  prophylaxis  to  a single patient more than once every two
     3  years, unless directed otherwise by a prescriber.
     4    (f)  The  pharmacist  provides  written  information, published by the
     5  department of health, to the patient on the ongoing use of  pre-exposure
     6  prophylaxis,  which  may  include  education  about side effects, safety
     7  during pregnancy and breastfeeding, adherence to recommended dosing, and
     8  the importance of timely testing and treatment, as applicable, for  HIV,
     9  renal function, hepatitis B, hepatitis C, sexually transmitted diseases,
    10  and  pregnancy for individuals of child-bearing capacity. The pharmacist
    11  shall notify the patient that the patient must be  seen  by  a  licensed
    12  physician  to  receive subsequent prescriptions for pre-exposure prophy-
    13  laxis; and
    14    (g) The pharmacist provides information, with the  patient's  consent,
    15  to  the patient or, when the patient lacks capacity to consent, a person
    16  authorized to consent to health care for such individual, on the  impor-
    17  tance of having a health care provider, developed by the commissioner of
    18  health,  and  if  the  patient  does not have a health care provider the
    19  pharmacist shall provide the patient  a  list  of  licensed  physicians,
    20  clinics,  or other health care service providers within the county where
    21  the pharmacist is located or adjacent counties.
    22    § 4. This act shall take effect on the one hundred eightieth day after
    23  it shall have become a law. Effective immediately, the addition,  amend-
    24  ment and/or repeal of any rule or regulation necessary for the implemen-
    25  tation  of  this act on its effective date are authorized to be made and
    26  completed on or before such date.
Go to top